search
Back to results

Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery

Primary Purpose

Colorectal Cancer

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
PillCam Colon 2
Colonoscopy
Sponsored by
IHU Strasbourg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Colorectal Cancer focused on measuring Colorectal cancer, Follow up, Colonoscopy, Videocapsule

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. patient between 18 and 85 years old
  2. patient with greater than 3 month follow-up for colorectal resection with ileo-colic , colo-colic or colorectal anastomosis, regardless of etiology
  3. patient requiring a colonoscopy for regular medical care
  4. absence of contra-indication to anesthesia and to colonoscopy conduct
  5. patient able to understand the study related information and to provide written informed consent
  6. patient registered with the French social security regime

Non-inclusion Criteria:

  1. absence of written informed consent
  2. patient having had a total colectomy
  3. patient with terminal stoma
  4. patient with clinical suspicion of intestinal stenosis and/or anastomotic stenosis
  5. patient with known Zenker diverticulum
  6. patient wearing a pacemaker or any other internal electronic medical device
  7. patient with deglutition disorders and/or altered state of consciousness
  8. patient with serious disease preventing planned study procedures
  9. pregnant or breast-feeding woman
  10. patient within exclusion period from other clinical trial
  11. patient having forfeited their freedom of an administrative or legal obligation
  12. patient being under guardianship

Sites / Locations

  • Department of Hepato-Gastroenterology, Nouvel Hopital Civil

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

PillCam COLON 2 and Standard Colonoscopy

Arm Description

Patients will have videocapsule colonoscopy after bowel preparation, followed by standard colonoscopy the next day. Interventions: Device: PillCam COLON 2 on D0 Procedure: Standard colonoscopy on D1

Outcomes

Primary Outcome Measures

Number of patients with full colonic exploration and detection of lesions
Number of patients for whom the capsule allowed for full colonic exploration and presence/absence of colorectal lesions detected by VCC compared to conventional colonoscopy

Secondary Outcome Measures

Anastomosis visualization
Anastomosis visualization by VCC and type (latero-lateral, termino-lateral, latero-terminal and termino-terminal)
Number and size of detected lesions
Number and size of detected lesions with VCC compared to conventional colonoscopy
Quality of colic preparation
Assessment of the quality of colic preparation for VCC (D0) and colonoscopy (D1)
Times related to videocapsule
Assessment of times related to videocapsule: Transit time of videocapsule : from ingestion to expulsion Reading time : time required for reading and analysing videocapsule recordings by gastroenterologist
Adverse events related to VCC exam and colonoscopy
Assessment of safety of each method. Recording of adverse events.
Patient's assessment of tolerability and acceptance
Patient ranking of tolerability and acceptance of each of the procedures using a visual analog scale
Health-economic assessment
Assessment of costs associated to each of the exams: Colonoscopy duration (OR entry - exit) Device cost (coloscope, capsule) Cost of medical exams related to each procedure (from pre-anesthesia to follow-up) Cost of medical time related to each procedure

Full Information

First Posted
June 14, 2013
Last Updated
April 9, 2019
Sponsor
IHU Strasbourg
search

1. Study Identification

Unique Protocol Identification Number
NCT01879943
Brief Title
Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery
Official Title
Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Terminated
Why Stopped
Operational difficulties related to medical staff turnover (investigators departure and sickness leave).
Study Start Date
October 18, 2013 (Actual)
Primary Completion Date
June 8, 2016 (Actual)
Study Completion Date
June 8, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
IHU Strasbourg

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The study will compare the diagnostic efficacy of the VCC (PillCam COLON 2) to standard colonoscopy in patients with prior colorectal surgery. The hypothesis is to validate the VCC as a means of screening for colonic polyps after resection, which would avoid a colonoscopy with its associated general anesthesia and potential side effects.
Detailed Description
Standard care after colorectal surgery is colon surveillance by standard colonoscopy with its benefits (gold standard examination, resection of lesions) and disadvantages (acceptability, general anesthesia, availability of qualified personnel, risk of perforation and associated gastrointestinal bleeding). Use of a video-capsule (VCC) is a new, non-invasive technique, that allows to visualize the colon as a whole. This technique has the advantage of not requiring general anesthesia or air insufflation. The examination is performed as an outpatient procedure and therefore does not require hospitalization. In previous studies, PillCam COLON 2 showed a good sensitivity and specificity in detecting colorectal lesions. However, its use requires an excellent bowel preparation. To date, no study has been conducted using the VCC in monitoring patients with prior colorectal surgery, especially on the passage of the VCC through surgical anastomosis. No information on VCC capabilities to view and recognize surgical anastomoses and VCC transit time in surgically modified colon is available. The possibility to precisely locate a colorectal lesion prior to surgery, using the VCC, also remains to be studied. The study requires a 2-month patient participation. The planned total study duration is 2 years.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
Colorectal cancer, Follow up, Colonoscopy, Videocapsule

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
N/A
Enrollment
37 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PillCam COLON 2 and Standard Colonoscopy
Arm Type
Experimental
Arm Description
Patients will have videocapsule colonoscopy after bowel preparation, followed by standard colonoscopy the next day. Interventions: Device: PillCam COLON 2 on D0 Procedure: Standard colonoscopy on D1
Intervention Type
Device
Intervention Name(s)
PillCam Colon 2
Intervention Description
PillCam® COLON 2 capsule endoscopy is a minimally invasive tool for direct visualization of the colon, including identifying the occurrence of polyps.
Intervention Type
Procedure
Intervention Name(s)
Colonoscopy
Intervention Description
Standard colonoscopy is the standard against which capsule endoscopy is compared.
Primary Outcome Measure Information:
Title
Number of patients with full colonic exploration and detection of lesions
Description
Number of patients for whom the capsule allowed for full colonic exploration and presence/absence of colorectal lesions detected by VCC compared to conventional colonoscopy
Time Frame
By the end of both procedures (Day 1)
Secondary Outcome Measure Information:
Title
Anastomosis visualization
Description
Anastomosis visualization by VCC and type (latero-lateral, termino-lateral, latero-terminal and termino-terminal)
Time Frame
Prior to colonoscopy on Day 1
Title
Number and size of detected lesions
Description
Number and size of detected lesions with VCC compared to conventional colonoscopy
Time Frame
By the end of both procedures (Day 1)
Title
Quality of colic preparation
Description
Assessment of the quality of colic preparation for VCC (D0) and colonoscopy (D1)
Time Frame
By the end of both procedures (Day 1)
Title
Times related to videocapsule
Description
Assessment of times related to videocapsule: Transit time of videocapsule : from ingestion to expulsion Reading time : time required for reading and analysing videocapsule recordings by gastroenterologist
Time Frame
Prior to colonoscopy on Day 1
Title
Adverse events related to VCC exam and colonoscopy
Description
Assessment of safety of each method. Recording of adverse events.
Time Frame
Until end of Day 1
Title
Patient's assessment of tolerability and acceptance
Description
Patient ranking of tolerability and acceptance of each of the procedures using a visual analog scale
Time Frame
Follow up visit (between Day 15 and Day 30)
Title
Health-economic assessment
Description
Assessment of costs associated to each of the exams: Colonoscopy duration (OR entry - exit) Device cost (coloscope, capsule) Cost of medical exams related to each procedure (from pre-anesthesia to follow-up) Cost of medical time related to each procedure
Time Frame
End of follow-up (between D15 and D30)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patient between 18 and 85 years old patient with greater than 3 month follow-up for colorectal resection with ileo-colic , colo-colic or colorectal anastomosis, regardless of etiology patient requiring a colonoscopy for regular medical care absence of contra-indication to anesthesia and to colonoscopy conduct patient able to understand the study related information and to provide written informed consent patient registered with the French social security regime Non-inclusion Criteria: absence of written informed consent patient having had a total colectomy patient with terminal stoma patient with clinical suspicion of intestinal stenosis and/or anastomotic stenosis patient with known Zenker diverticulum patient wearing a pacemaker or any other internal electronic medical device patient with deglutition disorders and/or altered state of consciousness patient with serious disease preventing planned study procedures pregnant or breast-feeding woman patient within exclusion period from other clinical trial patient having forfeited their freedom of an administrative or legal obligation patient being under guardianship
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michel Delvaux, MD
Organizational Affiliation
Department of Hepato-Gastroenterology, Nouvel Hopital Civil, Strasbourg, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Hepato-Gastroenterology, Nouvel Hopital Civil
City
Strasbourg
ZIP/Postal Code
67000
Country
France

12. IPD Sharing Statement

Learn more about this trial

Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery

We'll reach out to this number within 24 hrs